Entheos Labs

https://lnkd.in/d4i5PMxH Darrick Balu Tristan Edwards Stephen Haggarty Jerry Rosenbaum

Friday March 7th Time: 12-4 PM Location: Massachusetts State House Address: 24 Beacon St., Boston, MA, 02133 #SUFS2025

We at Dragonfly 44 Capital (D44) want to extend our heartfelt thanks to everyone who joined us at the “Investing in Mental Health Innovation: Perspectives from Policy, Venture, and Entrepreneurs” reception during the 2025 J.P. Morgan Healthcare Conference. It was an absolute privilege to co-host this event with our partners at Meadows Mental Health Policy Institute and GreyMatter. A special thank you to our keynote speaker, Thomas Insel MD, whose insights into mental health research, policy, and innovation set the tone for the evening. We are also grateful to the companies that showcased their cutting-edge solutions in neuropsychiatry and digital mental health, including Tactogen, Stillmind Therapeutics, Circular Genomics, Nema Health, Finni Health (YC W23), Omniscient Neurotechnology (o8t), Soulside, Entheos Labs, Applied Cognition, Sanmai Technologies PBC, and BRAiN Tx. Your presentations highlighted the promise of this evolving space. From policy updates and venture investment perspectives to meaningful networking opportunities, the reception was a testament to the power of collaboration in fueling mental health innovation. Thank you for making the evening a resounding success. We look forward to continuing these conversations and fostering partnerships that drive progress in this important field. If you weren’t able to attend or still want to connect, you can book 1x1 meetings with select companies through our dedicated page here: https://lnkd.in/dPby6_wR Here’s to advancing mental health solutions—together! #D44Capital #MentalHealthInnovation #JPMPerspectives #PolicyAndVenture #Neuropsychiatry #DigitalMentalHealth #HealthcareConference #Collaboration Danish M. Kacie Kelly Harris Eyre Anna Wang

I'm excited to be presenting on behalf of Entheos Labs at the 2025 JPM Mental Health & Neuroscience Welcome Reception on Monday Jan. 13th. https://lnkd.in/ePK5xuXz In collaboration with Mass General Hospital, Entheos Labs is on a mission to revolutionize brain health treatments by advancing the neuroscience of psychedelics. Investors can book a time for 1:1 meetings with me at JPM through the scheduling link here:?https://lnkd.in/e8PdgXSN? Tristan Edwards Jerry Rosenbaum Stephen Haggarty Jacob Hooker Dragonfly 44 Capital Michael Brotherton Joe Hashmall Daniela Pauli #JPM2025 #psychedelics

Great review by Entheos’ MGH co-founders Stephen Haggarty Jerry Rosenbaum Tristan Edwards Darrick Balu

We're excited for our CSO Darrick Balu to present at the D44/GreyMatter Mental Health & Neuroscience Welcome Reception and look forward to meeting with investors. Tristan Edwards Jerry Rosenbaum Stephen Haggarty Michael Brotherton Joe Hashmall https://lnkd.in/es4Tdqex https://lnkd.in/eg6ZaSMc

Great news article highlighting the exciting work being done by Entheos Labs MGH cofounders. Stephen Haggarty Darrick Balu Tristan Edwards Jerry Rosenbaum Jacob Hooker #psychedelics https://lnkd.in/efsUU2sG

Massachusetts General Hospital is proud to be an Honor Roll Hospital and ranked #1 in Psychiatry in the nation by U.S. News & World Report. Learn more: https://spklr.io/6041SUHT

The 4th Annual Psychedelic Therapeutics and Drug Development Conference is now just a little over a week away. We're thrilled to be hosting scientists, clinical development professionals, C-level executives, advocates, non-profit leaders and many others at our upcoming event in Boston on May 23rd and 24th. Our speakers and panelists will be tackling a diverse range of topics at this year's event, including: - Optimization of psychedelic trials - Clinical progress and data-to-date for key psychedelic therapies in development - Navigating the various legal challenges in researching psychedelics - Psychedelics manufacturing issues - Raising funds for psychedelic drug programs - Pain and the potential for psychedelics - Psychedelic clinical trial design - Unlocking reimbursement for psychedelic therapies - Psychedelic rescheduling efforts Plus many more topics. You can still register at https://lnkd.in/eM5iiPn. We're looking forward to a fantastic event with a scientific poster session and a host of exhibitors sharing their knowledge, insights and solutions for academic and industry research. Learn more about this event, register and/or join our mailing list by visiting https://lnkd.in/eM5iiPn. #psychedelics #psychedelicresearch #psychedelictherapy #boston Christian Gray Peter Hendricks Deborah C. Mash Alan Kozikowski Bernard Lerer Charles Nichols Bill Ciprick Christine Moore, PhD Ritchie Patton Jeeshan Chowdhury Graham Pechenik George McBride Jennifer Jewell Manesh Girn Brett Waters Kimberly Chew Ed Christian David Esselman Amelia Furbish Anthony Coulson Elizabeth Nielson, Ph.D Michael Oshinsky Megan Francis Gregory Ryslik Shobi Ahmed, MD, PhD Gabriel Aranovich, MD Julia Forte Darrick Balu Dan Rome, MD Vitaly Napadow Jeremy Forest Mark Theeuwes Mark Rasenick Todd M. Solomon, PhD Danielle Schlosser, PhD Amie Leighton